NDC 64896-671

ZOMIG

Zolmitriptan

ZOMIG is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Impax Specialty Pharma. The primary component is Zolmitriptan.

Product ID64896-671_51dce449-5220-4582-ba49-b10580ec5009
NDC64896-671
Product TypeHuman Prescription Drug
Proprietary NameZOMIG
Generic NameZolmitriptan
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2012-04-02
Marketing CategoryNDA / NDA
Application NumberNDA020768
Labeler NameImpax Specialty Pharma
Substance NameZOLMITRIPTAN
Active Ingredient Strength3 mg/1
Pharm ClassesSerotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 64896-671-49

1 BLISTER PACK in 1 CARTON (64896-671-49) > 2 TABLET in 1 BLISTER PACK
Marketing Start Date2012-04-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 64896-671-49 [64896067149]

ZOMIG TABLET
Marketing CategoryNDA
Application NumberNDA020768
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-04-02

NDC 64896-671-51 [64896067151]

ZOMIG TABLET
Marketing CategoryNDA
Application NumberNDA020768
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-04-02

Drug Details

Active Ingredients

IngredientStrength
ZOLMITRIPTAN2.5 mg/1

OpenFDA Data

SPL SET ID:df93b636-103f-4fb5-26b6-50f639e29b1d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 200193
  • 200194
  • 213167
  • 284201
  • 351134
  • 153353
  • 901802
  • 901803
  • Pharmacological Class

    • Serotonin 1b Receptor Agonists [MoA]
    • Serotonin 1d Receptor Agonists [MoA]
    • Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

    Medicade Reported Pricing

    64896067151 ZOMIG 2.5 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "ZOMIG" or generic name "Zolmitriptan"

    NDCBrand NameGeneric Name
    21695-955ZOMIGZolmitriptan
    68258-7103ZOMIGZOMIG
    64896-682ZOMIGZOMIG
    64896-672ZOMIGZOMIG
    64896-681ZOMIGZOMIG
    64896-671ZOMIGZOMIG
    0115-0671ZolmitriptanZolmitriptan
    0115-0672ZolmitriptanZolmitriptan
    16571-803ZolmitriptanZolmitriptan
    16571-804ZolmitriptanZolmitriptan
    27241-021ZolmitriptanZolmitriptan
    27241-022ZolmitriptanZolmitriptan
    31722-458ZOLMITRIPTANZOLMITRIPTAN
    31722-459ZOLMITRIPTANZOLMITRIPTAN
    33342-112ZolmitriptanZolmitriptan
    33342-113ZolmitriptanZolmitriptan
    33342-139ZolmitriptanZolmitriptan
    33342-140ZolmitriptanZolmitriptan
    45802-711zolmitriptanzolmitriptan
    46708-181ZolmitriptanZolmitriptan
    46708-182ZolmitriptanZolmitriptan
    46708-462ZolmitriptanZolmitriptan
    46708-463ZolmitriptanZolmitriptan
    50742-625ZolmitriptanZolmitriptan
    50742-626ZolmitriptanZolmitriptan
    55700-943ZolmitriptanZolmitriptan
    55700-944ZolmitriptanZolmitriptan
    55801-322ZolmitriptanZolmitriptan
    55801-323ZolmitriptanZolmitriptan
    59746-432ZolmitriptanZolmitriptan
    59746-433ZolmitriptanZolmitriptan
    59746-461Zolmitriptan ODZolmitriptan
    59746-462Zolmitriptan ODZolmitriptan
    0115-0691Zolmitriptan Orally DisintegratingZolmitriptan
    0115-0692Zolmitriptan Orally DisintegratingZolmitriptan

    Trademark Results [ZOMIG]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ZOMIG
    ZOMIG
    74719034 2175295 Live/Registered
    Wellcome Foundation Limited, The
    1995-08-22

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.